BridgeBio Pharma's market cap is currently $6.71B. The company's EPS TTM is $-2.412; its P/E ratio is ―; BridgeBio Pharma is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.95. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 9.30M	$ 77.65M	$ 69.72M	$ 8.25M	$ 40.56M
Gross Profit	$ 6.86M	$ 74.21M	$ 66.60M	$ 5.16M	$ 38.06M
Operating Income	$ -607.37M	$ -471.87M	$ -579.75M	$ -474.48M	$ -266.24M
EBITDA	$ -565.47M	$ -397.44M	$ -533.83M	$ -465.75M	$ -279.82M
Net Income	$ -643.20M	$ -493.96M	$ -639.30M	$ -483.93M	$ -260.44M
Balance Sheet
Cash & Short-Term Investments	$ 434.88M	$ 428.27M	$ 787.51M	$ 607.09M	$ 577.14M
Total Assets	$ 546.38M	$ 623.04M	$ 1.01B	$ 703.59M	$ 631.68M
Total Debt	$ 1.74B	$ 1.72B	$ 1.73B	$ 495.79M	$ 99.79M
Net Debt	$ 1.36B	$ 1.35B	$ 1.33B	$ 139.71M	$ -263.98M
Total Liabilities	$ 1.89B	$ 1.87B	$ 1.88B	$ 595.70M	$ 155.70M
Stockholders' Equity	$ -1.35B	$ -1.25B	$ -870.41M	$ 57.91M	$ 408.45M
Cash Flow
Free Cash Flow	$ -529.03M	$ -425.81M	$ -546.18M	$ -407.23M	$ -258.73M
Operating Cash Flow	$ -527.72M	$ -419.49M	$ -497.93M	$ -399.71M	$ -253.59M
Investing Cash Flow	$ 54.03M	$ 453.15M	$ -200.83M	$ -52.99M	$ -217.25M
Financing Cash Flow	$ 451.54M	$ -13.13M	$ 736.45M	$ 447.19M	$ 398.79M

Currency in USD

BridgeBio Pharma Earnings and Revenue History

Income Statement >

BridgeBio Pharma Debt to Assets

Balance Sheet >

BridgeBio Pharma Cash Flow

Cash Flow >

BridgeBio Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing